3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Classical hematology
1
Conditions
Myelodysplastic Syndromes
17
Leukemia, Myeloid, Acute
16
Leukemia
15
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Lymphoma
7
Leukemia, Lymphocytic, Chronic, B-Cell
5
Hematologic Diseases
5
Multiple Myeloma
4
Lymphoma, Non-Hodgkin
4
Leukemia, Biphenotypic, Acute
4
Hodgkin Disease
4
Graft vs Host Disease
4
Myeloproliferative Disorders
3
Leukemia, Myeloid
3
Hematologic Neoplasms
3
Preleukemia
2
Precancerous Conditions
2
Neoplasms by Histologic Type
2
Neoplasms
2
Lymphoproliferative Disorders
2
Lymphatic Diseases
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Lymphoid
2
Leukemia, B-Cell
2
Immunoproliferative Disorders
2
Immune System Diseases
2
Bone Marrow Diseases
2
Blast Crisis
2
Thrombocythemia, Essential
1
Interventions
fludarabine phosphate
3
Cyclophosphamide
3
Whole-Body Irradiation
2
Thiotepa
2
Melphalan
2
Busulfan
2
Alemtuzumab
2
AP 1903 reagent
2
fludarabine
1
Tacrolimus
1
Peripheral Blood Stem Cell Transplantation
1
Methylprednisolone Hemisuccinate
1
Methylprednisolone
1
Bone Marrow Transplantation
1
Antilymphocyte Serum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Anemia, Sickle Cell
×
Bone Marrow Transplantation
×
Myeloid
×
Clear all
NCT07145411
2025-08-28
HOPE
Ossium Health, Inc.
Recruiting
10 enrolled